Details for Patent: 11,679,210
✉ Email this page to a colleague
Which drugs does patent 11,679,210 protect, and when does it expire?
Patent 11,679,210 protects RYALTRIS and is included in one NDA.
This patent has eighty-eight patent family members in thirty-two countries.
Drugs Protected by US Patent 11,679,210
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Specialty | RYALTRIS | mometasone furoate; olopatadine hydrochloride | SPRAY, METERED;NASAL | 211746-001 | Jan 13, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,679,210
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2018260934 | ⤷ Try a Trial | |||
Australia | 2019224850 | ⤷ Try a Trial | |||
Australia | 2023270308 | ⤷ Try a Trial | |||
Brazil | 112015018252 | ⤷ Try a Trial | |||
Brazil | 112018076537 | ⤷ Try a Trial | |||
Brazil | 112020016817 | ⤷ Try a Trial | |||
Canada | 3023355 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |